TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 52 filers reported holding TARSUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,754,623 | +7.5% | 211,290 | +9.3% | 0.00% | 0.0% |
| Q2 2023 | $3,492,624 | +83.6% | 193,283 | +27.7% | 0.00% | – |
| Q1 2023 | $1,902,671 | -16.0% | 151,366 | -2.0% | 0.00% | – |
| Q4 2022 | $2,265,190 | -11.7% | 154,515 | +3.2% | 0.00% | -100.0% |
| Q3 2022 | $2,564,000 | +26.2% | 149,783 | +7.6% | 0.00% | – |
| Q2 2022 | $2,031,000 | +75.7% | 139,147 | +102.4% | 0.00% | – |
| Q1 2022 | $1,156,000 | -28.4% | 68,732 | -4.2% | 0.00% | – |
| Q4 2021 | $1,615,000 | +1.3% | 71,781 | -3.0% | 0.00% | – |
| Q3 2021 | $1,595,000 | -30.9% | 74,011 | -7.1% | 0.00% | – |
| Q2 2021 | $2,308,000 | +6.9% | 79,635 | +18.8% | 0.00% | – |
| Q1 2021 | $2,160,000 | -25.7% | 67,035 | -4.8% | 0.00% | -100.0% |
| Q4 2020 | $2,909,000 | – | 70,399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,779,158 | $32,149,385 | 4.73% |
| COWEN AND COMPANY, LLC | 1,999,383 | $36,128,850 | 3.00% |
| Vivo Capital, LLC | 2,262,200 | $40,877,954 | 2.82% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $32,300,613 | 1.93% |
| Cormorant Asset Management, LP | 1,421,422 | $25,685,096 | 1.44% |
| Sands Capital Ventures, LLC | 260,000 | $4,698,200 | 1.39% |
| Ghost Tree Capital, LLC | 150,000 | $2,710,500 | 0.90% |
| RTW INVESTMENTS, LP | 2,548,125 | $46,044,619 | 0.88% |
| Perceptive Advisors | 1,296,416 | $23,426,237 | 0.68% |
| TFG Asset Management GP Ltd | 165,000 | $2,981,550 | 0.40% |